Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Public ClinicalTrials.gov record NCT06100939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus (APRICITY-A)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Study identification
- NCT ID
- NCT06100939
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 396 participants
Conditions and interventions
Conditions
Interventions
- Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment Combination Product
- Placebo and sham treatment Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 8 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 30, 2023 (Actual)
- Primary completion
- May 27, 2026 (Actual)
- Completion
- Jun 12, 2026 (Actual)
- Last update posted
- Jun 25, 2026
2023 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nvision Eye Centers Rowland Heights | Rowland Heights | California | 91748 | — |
| Goodman Eye Center | San Francisco | California | 94115 | — |
| Center for Excellence in Eye Care | Miami | Florida | 33176 | — |
| Chicago Cornea Consultants | Hoffman Estates | Illinois | 60169 | — |
| Boston Vision | Brookline | Massachusetts | 02445 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| The Eye Doctors at CNY Eye Care | East Syracuse | New York | 13057 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45219 | — |
| Devers Eye Institute | Portland | Oregon | 97210 | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| UPMC Vision Institute | Pittsburgh | Pennsylvania | 15219 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06100939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06100939 live on ClinicalTrials.gov.